Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPS
Clinical trial NCT06159114 · COMPLETED
Trial details
- NCT number
- NCT06159114
- Sponsor
- Xintian Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-19
- Primary completion
- 2025-01-31
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.